US Patent Issued to Takeda Pharmaceutical on Oct. 14 for "Assays for determining plasma kallikrein system biomarkers" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,824, issued on Oct. 14, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Assays for determining plasma kallikrein system biomarkers" was invented by Daniel J. Sexton (Melrose, Mass.), Ryan Faucette (Melrose, Mass.), Jon A. Kenniston (Hingham, Mass.), Gregory P. Conley (Arlington, Mass.), Andrew Nixon (Hanover, Mass.), Christopher TenHoor (Hopkinton, Mass.) and Burt Adelman (Concord, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system."

The patent was file...